Chunli Medical places great emphasis on the development and widespread adoption of high-end orthopedic implant devices.

Release Date:

2025-11-04

Author:


Chunli Medical places great emphasis on the development and clinical application of high‑end orthopedic implant devices. It has established a long‑term collaborative partnership with Suzhou Ding’an Technology Co., Ltd. and jointly founded the “Joint Laboratory for the Engineering Application of Biomedical Ceramics.” Leveraging the pressing clinical needs for advanced orthopedic implants—such as bone defect‑filling and repair materials—and its own proprietary core technologies, the company has undertaken preliminary explorations into the engineering applications of key technologies related to the in situ synthesis of BCP micro‑ and nanoscale powders, as well as fundamental research on the physicochemical properties and biocompatibility of these in situ‑synthesized BCP powders. These efforts have helped address several engineering challenges in the industrialization of high‑end orthopedic implant devices, including bioactive ceramic artificial bones.